Naoki Koide

Naoki Koide

Auto-generated profile, based on publicly available information

Naoki Koide

Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2007 in Innate Immunity
Verified
Journal Article
Open access
NKNaoki Koide
Naoki Koide
MMMya Mya Mu
Mya Mya Mu
FHFerdaus Hassan
Ferdaus Hassan
SIShamima Islam
Shamima Islam
GTGantsetseg Tumurkhuu
Gantsetseg Tumurkhuu
TYTakashi Yokochi
Takashi Yokochi
Lipopolysaccharide (LPS) enhances the production of nitric oxide (NO) in interferon (IFN)-γstimulated vascular endothelial cells. We studied the mechanism by which LPS enhances IFN-γ-induced NO production by using the murine vascular endothelial cell line, END-D. LPS enhanced IFN-γinduced NO production via augmented expression of inducible type NO synthase (iNOS) mRNA. LPS significantly augmented the activation of interferon regulatory factor (IRF)-1 in IFN-γ-stimulated END-D cells, although it did not affect the activation of either MyD88-dependent nuclear factor (NF)-κB or MyD88-independent IRF-3. SB203580, an inhibitor of p38 mitogen-activated protein kinase (MAPK), prevented the nuclear translocation of IRF-1 in LPS and IFN-γ-stimulated END-D cells, and inhibited the iNOS expression and NO production in those cells. Therefore, it is proposed that LPS enhanced NO production in IFN-γ-stimulated END-D cells via augmenting p38 MAPKmediated IRF-1 activation.

1 July 2006 in FEMS Microbiology Letters
Verified
Journal Article
Open access
PDF file
TYTomoaki Yoshida
Tomoaki Yoshida
NKNaoki Koide
Naoki Koide
IMIsamu Mori
Isamu Mori
HIHiroyasu Ito
Hiroyasu Ito
TYTakashi Yokochi
Takashi Yokochi
Many studies indicate that Chlamydia pneumoniae infection is a crucial risk factor in atherogenesis. The most relevant cell type for the pathogenesis

13 November 2013 in Innate Immunity
Verified
Journal Article
Closed access
NKNaoki Koide
Naoki Koide
EOErdenezaya Odkhuu
Erdenezaya Odkhuu
YNYoshikazu Naiki
Yoshikazu Naiki
BTBilegtsaikhan Tsolmongyn
Bilegtsaikhan Tsolmongyn
KIKiyoaki Ito
Kiyoaki Ito
TYTakashi Yokochi
Takashi Yokochi
The effect of LPS on the production of vascular endothelial growth factor (VEGF) was examined using RAW 264.7 macrophage cells. LPS induced VEGF production in RAW 264.7 cells and mouse peritoneal cells. LPS induced VEGF production via the expression of hypoxia inducible factor-1α and LPS-induced VEGF production was dependent on the activation of p38 MAPK and NF-κB activation· Transforming growth factor (TGF)-β1 augmented LPS-induced VEGF production, although TGF-β1 alone did not induce VEGF production. The augmentation of LPS-induced VEGF production by TGF-β1 was inhibited by a p38 MAPK inhibitor and was correlated with the phosphorylation of Smad3. The enhancing effect of TGF-β1 on LPS-induced VEGF production was observed in vivo in the skin lesions of mice receiving a subcutaneous injection of LPS. Taken together, it is suggested that LPS induced the VEGF production in macrophages and that it was augmented by TGF-β1 in vitro and in vivo.

1 February 2004 in Innate Immunity
Verified
Journal Article
Closed access
AMAkiko Morikawa
Akiko Morikawa
TSTsuyoshi Sugiyama
Tsuyoshi Sugiyama
NKNaoki Koide
Naoki Koide
IMIsamu Mori
Isamu Mori
MMMya Mya Mu
Mya Mya Mu
TYTakashi Yokochi
Takashi Yokochi
The effect of butyrate, a natural bacterial product of colonic bacterial flora, on nitric oxide (NO) production in murine vascular endothelial cell line END-D in response to IFN-gamma and/or LPS was studied. Butyrate significantly augmented NO production in END-D cells in response to IFN-gamma or IFN-gamma + LPS, but not LPS alone. The NO production was augmented by the addition of butyrate until 6 h after the stimulation with IFN-gamma or IFN-gamma + LPS. The augmentation was abolished by the removal of butyrate from the cultures. Butyrate enhanced the expression of inducible type NO synthase (iNOS) in the stimulated END-D cells. Furthermore, butyrate-enhanced NO production in the presence of various signal inhibitors down-regulating the signal pathways using nuclear factor (NF)-kappaB, mitogen-activated protein (MAP) kinases and Janus tyrosine kinase. The putative mechanism of butyrate-induced augmentation of NO production in response to IFN-gamma or IFN-gamma + LPS is discussed.

27 September 2007 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
NKN. Koide
N. Koide
AMA. Morikawa
A. Morikawa
GTG. Tumurkhuu
G. Tumurkhuu
JDJ. Dagvadorj
J. Dagvadorj
FHF. Hassan
F. Hassan
TYT. Yokochi
T. Yokochi
The effect of interferon (IFN)-γ and/or lipopolysaccharide (LPS) on Fas-mediated cell death with anti-Fas agonistic antibody in vascular endothelial cells was examined using a mouse END-D cell line. Anti-Fas agonistic antibody exhibited cytotoxic actions on END-D cells. Fas-mediated cell death was enhanced by LPS or IFN-γ. The combination of IFN-γ and LPS significantly enhanced cell death compared to IFN-γ or LPS alone. IFN-γ and LPS augmented cell surface expression of Fas, but not tumour necrosis factor (TNF) receptor 1. Inhibitors of p38 mitogen-activated protein kinase (MAPK) prevented augmentation of Fas expression in IFN-γ and LPS-treated END-D cells. IFN-γ and LPS-treated END-D cells did not become susceptible to TNF-α or nitric oxide-mediated cytotoxicity. IFN-γ and LPS thus appear to augment selectively Fas expression via activation of p38 MAPK and enhance Fas-mediated cell death in END-D cells. Furthermore, administration of IFN-γ and LPS into mice induced in vivo expression of Fas on vascular endothelial cells and Fas ligand (FasL) on peripheral blood leucocytes. The relationship between enhancement of Fas-mediated cell death by IFN-γ and LPS and the development of vascular endothelial injury is discussed.

1 September 2014 in Immunology Letters
Verified
Journal Article
Closed access
NKNaoki Koide
Naoki Koide
YKYuichiro Kondo
Yuichiro Kondo
EOErdenezaya Odkhuu
Erdenezaya Odkhuu
JUJambalganiin Ulziisaikhan
Jambalganiin Ulziisaikhan
TUTamami Ukaji
Tamami Ukaji
KUKazuo Umezawa
Kazuo Umezawa